Education
About Us
Working with TipRanks
Follow Us
NeoGenomics (NEO)
NASDAQ:NEO
Total Valuation
NeoGenomics has a market cap or net worth of $953.63M. The enterprise value is $465.76M.
Market Cap$953.63M
Enterprise Value$465.76M
Share Statistics
NeoGenomics has 128,694,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding128,694,500
Owned by Insiders1.12%
Owned by Institutions23.24%
Financial Efficiency
NeoGenomics’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -5.85%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-5.85%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee300.26K
Profits Per Employee-35.78K
Employee Count2,200
Asset Turnover0.40
Inventory Turnover13.85
Valuation Ratios
The current PE Ratio of NeoGenomics is -5.30. NeoGenomics’s PEG ratio is -1.64.
PE Ratio-5.30
PS Ratio0.00
PB Ratio0.23
Price to Fair Value0.46
Price to FCF-6.40
Price to Operating Cash Flow26.94
PEG Ratio-1.64
Income Statement
In the last 12 months, NeoGenomics had revenue of 660.57M and earned -78.73M in profits. Earnings per share was -3.10.
Revenue660.57M
Gross Profit290.10M
Operating Income-92.11M
Pretax Income-80.67M
Net Income-78.73M
EBITDA-1.51M
Earnings Per Share (EPS)-3.10
Cash Flow
In the last 12 months, operating cash flow was 7.61M and capital expenditures -39.98M, giving a free cash flow of -32.37M billion.
Operating Cash Flow7.61M
Free Cash Flow-32.37M
Free Cash Flow per Share-0.25
Dividends & Yields
NeoGenomics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.22
52-Week Price Change-47.56%
50-Day Moving Average8.84
200-Day Moving Average13.39
Relative Strength Index (RSI)39.38
Average Volume (3m)2.60M
Important Dates
NeoGenomics upcoming earnings date is Jul 30, 2025, TBA Not Confirmed.
Last Earnings DateApr 29, 2025
Next Earnings DateJul 30, 2025
Ex-Dividend Date―
Financial Position
NeoGenomics as a current ratio of 1.98, with Debt / Equity ratio of 68.09%
Current Ratio1.98
Quick Ratio1.89
Debt to Market Cap1.30
Net Debt to EBITDA-157.72
Interest Coverage Ratio-13.92
Taxes
In the past 12 months, NeoGenomics has paid -1.95M in taxes.
Income Tax-1.95M
Effective Tax Rate0.02
Enterprise Valuation
NeoGenomics EV to EBITDA ratio is -1.54K, with an EV/FCF ratio of -68.32.
EV to Sales3.52
EV to EBITDA-1.54K
EV to Free Cash Flow-68.32
EV to Operating Cash Flow331.15
Balance Sheet
NeoGenomics has $358.08M in cash and marketable securities with $604.78M in debt, giving a net cash position of $246.70M billion.
Cash & Marketable Securities$358.08M
Total Debt$604.78M
Net Cash$246.70M
Net Cash Per Share$1.92
Tangible Book Value Per Share$0.31
Margins
Gross margin is 43.79%, with operating margin of -13.94%, and net profit margin of -11.92%.
Gross Margin43.79%
Operating Margin-13.94%
Pretax Margin-12.21%
Net Profit Margin-11.92%
EBITDA Margin-0.23%
EBIT Margin-11.21%
Analyst Forecast
The average price target for NeoGenomics is $12.72, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$12.72
Price Target Upside71.66% Upside
Analyst ConsensusModerate Buy
Analyst Count12
Revenue Growth Forecast10.10%
EPS Growth Forecast8.79%